InsiderDB

Rep. Daniel S. Goldman sold Syneos Health (SYNH)

Rep. Daniel S. Goldman (D-NY-10) · $1K–$15K · traded Jan 31, 2023

Transaction
Sold
Amount
$1K–$15K
Owner
Not stated
Traded
Jan 31, 2023
Disclosed
Feb 24, 2023
Days to disclose
24
Asset type
Stock
As filed
Syneos Health, Inc. - Class A
Industry
Medical - Diagnostics & Research · Healthcare

Other trades in this filing

All of Goldman's trades →

Recent Congress trades in SYNH

Company context for SYNH

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. SYNHLobbying report·Lobbying disclosures

    SYNH: third_quarter 2026 lobbying report

    Clinical trials and research. Remote clinical trials, biomedical research & development. Business and corporate tax issues, international tax reform; issues related to research and development.

    Public: Oct 20, 2026, 5:31 PM EDTOriginal source ↗
  2. SYNHLobbying report·Lobbying disclosures

    SYNH: second_quarter 2026 lobbying report

    Clinical trials and research. Remote clinical trials, biomedical research & development. Business and corporate tax issues, international tax reform; issues related to research and development.

    Public: Jul 20, 2026, 3:25 PM EDTOriginal source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.